Summary of Classification and Labelling
Notified classification and labelling
General Information
225-490-5 |
(3α,16α)-eburnamenin-14(15H)-one |
4880-88-0 |
Notified classification and labelling according to CLP criteria
STOT RE 2 |
H373
(not specified)
(dermal)
|
H373
|
|
GHS08 Wng
|
|
|
|
|
1 |
|
View details
|
STOT RE 2 |
H373
(not specified)
(oral)
|
H373
|
STOT RE 2 |
H373
(not specified)
(inhalation)
|
H373
|
Number of Aggregated Notifications: 1